Archive: 21/11/2014
Investigational drug reduces high potassium levels in chronic kidney disease patients
Research published today found that the investigational drug patiromer decreased high potassium levels and maintained normal potassium levels in patients with chronic kidney disease. The results of a multicenter trial appear ...
Nov 21, 2014
Clipping proteins that package genes may limit abnormal cell growth in tumors
Changes to the structure of the protein histone H3.3 may play a key role in silencing genes that regulate cancer cell growth, according to a study led by researchers from the Icahn School of Medicine at Mount Sinai and published ...
Nov 21, 2014
Research shows anti-HIV medicines can cause damage to fetal hearts
A study by a Wayne State University and Children's Hospital of Michigan, Detroit Medical Center research team is shedding new light on the troubling question of whether the drugs often given to HIV-positive pregnant women ...
Nov 21, 2014
Doctor working in Sierra Leone is Italy's first Ebola case (Update)
An Italian doctor has contracted Ebola in Sierra Leone and is being flown back to Rome for specialist treatment, the health ministry said Monday.
Nov 21, 2014
Digoxin associated with higher risk of death and hospitalization
Digoxin, a drug commonly used to treat heart conditions, was associated with a 71 percent higher risk of death and a 63 percent higher risk of hospitalization among adults with diagnosed atrial fibrillation and no evidence ...
Nov 21, 2014
Immune checkpoint inhibitors may work in brain cancers
New evidence that immune checkpoint inhibitors may work in glioblastoma and brain metastases was presented today by Dr Anna Sophie Berghoff at the ESMO Symposium on Immuno-Oncology 2014 in Geneva, Switzerland.
Nov 21, 2014